• #463604
  • AbbVie Inc #00074104008

Survanta* Beractant 25 mg / mL Intratracheal Suspension Vial 8 mL

SURVANTA , VL 25MG/ML 8ML ABTLAB

No Image

Features
  • SURVANTA is indicated for prevention and treatment (“rescue%XE2%X80?) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants
  • Store refrigerated at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit)
  • More …
Volume
4 mL 8 mL
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #463604
Manufacturer #00074104008
BrandSurvanta*
ManufacturerAbbVie Inc
Country of OriginUnknown
Alternate Manufacturer Number1349844
ApplicationPulmonary Surfactant
Container TypeVial
Dosage FormSuspension
Generic Drug Code02871
Generic Drug NameBeractant
NDC Number00074-1040-08
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Storage RequirementsRequires Refrigeration
Strength25 mg / mL
TypeIntratracheal
UNSPSC Code51161702
Volume8 mL
Features
  • SURVANTA is indicated for prevention and treatment (“rescue%XE2%X80?) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants
  • Store refrigerated at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit)
More Information